GROUP ONE TRADING, L.P. - NEOLEUKIN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,248
+18.5%
1,5040.0%0.00%
Q1 2023$1,053
+3.3%
1,504
-24.8%
0.00%
Q4 2022$1,019
+1.9%
2,0010.0%0.00%
Q3 2022$1,000
-50.0%
2,0010.0%0.00%
Q2 2022$2,000
-88.2%
2,001
-77.3%
0.00%
Q1 2022$17,000
+466.7%
8,800
+1157.1%
0.00%
Q4 2021$3,000
+200.0%
700
+600.0%
0.00%
Q1 2021$1,0001000.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,156,200$10,672,0001.77%
ACT CAPITAL MANAGEMENT, LLC 239,000$2,207,0001.13%
EcoR1 Capital, LLC 2,358,804$21,772,0000.81%
Redmile Group, LLC 3,919,235$36,175,0000.54%
Boxer Capital, LLC 1,501,058$13,855,0000.49%
Baker Brothers Advisors 3,821,740$35,275,0000.16%
Sio Capital Management, LLC 38,312$354,0000.09%
Highland Private Wealth Management 46,999$434,0000.06%
PERSONAL CFO SOLUTIONS, LLC 23,710$219,0000.04%
Point72 Asset Management, L.P. 883,102$8,151,0000.04%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders